Aclarion Provides Corporate Update on Nociscan AI Technology Milestones [Yahoo! Finance]
Aclarion, Inc. (ACON)
Company Research
Source: Yahoo! Finance
Progressing with proven path toward standard of care addressing chronic low back pain, the largest expenditure in US healthcare costing Americans an estimated $134 Billion annually More than $50 Million has been invested in the promising Aclarion AI platform that aids physicians in identification of painful discs Technology protected by 23 issued US patents, 17 issued international patents, and 12 pending patent applications Three of four largest private insurance payers in the UK now covering Nociscan Partnership with ten prominent KOL surgeons signed on to assist Aclarion in successfully gaining traction and reimbursement throughout the United States BROOMFIELD, CO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today provided a corpor
Show less
Read more
Impact Snapshot
Event Time:
ACON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACON alerts
High impacting Aclarion, Inc. news events
Weekly update
A roundup of the hottest topics
ACON
News
- Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes [Yahoo! Finance]Yahoo! Finance
- Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesGlobeNewswire
- PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologyGlobeNewswire
- Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesGlobeNewswire
- Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial [Yahoo! Finance]Yahoo! Finance
ACON
Sec Filings
- 9/24/24 - Form 8-K
- 9/24/24 - Form 424B5
- 9/24/24 - Form EFFECT
- ACON's page on the SEC website